This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Devoy, A. F.
Right arrow Articles by Martin, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devoy, A. F.
Right arrow Articles by Martin, D. R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2005, p. 832-837, Vol. 43, No. 2
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.2.832-837.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Stability of PorA during a Meningococcal Disease Epidemic

A. F. Devoy,{dagger} K. H. Dyet, and D. R. Martin*

Communicable Disease Group, Institute of Environmental Science and Research, Porirua, New Zealand

Received 21 June 2004/ Returned for modification 23 August 2004/ Accepted 16 September 2004

Meningococci causing New Zealand's epidemic, which began in 1991, are defined as group B, serosubtype P1.4 (subtype P1.7-2,4), belonging to the ST-41/ST-44 complex, lineage III. Of the 2,358 group B isolates obtained from disease cases from 1991 through 2003, 85.7% (2,021 of 2,358) were determined to be serosubtype P1.4. Of the remaining isolates, 156 (6.6%) were not serosubtypeable (NST). Molecular analysis of the porA gene from these B:NST meningococcal isolates was used to determine the reason. Most NST isolates (156, 88.5%) expressed a PorA that was distinct from P1.7-2,4 PorA. Fifteen isolates expressed variants of P1.7-2,4 PorA, and a further three expressed P1.7-2,4 PorA without any sequence variation. These three isolates expressed P1.7-2,4 PorA at very low levels, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis, and showed variation in the porA promoter region. Among the 15 meningococcal isolates expressing variants of P1.7-2,4 PorA, 11 different sequence variations were found. Compared with the P1.7-2,4 PorA sequence, the sequences of these variants contained deletions, insertions, or single-nucleotide substitutions in the VR2 region of the protein. Multilocus restriction typing was used to assess the clonal derivations of B:NST case isolates. Meningococcal isolates expressing distinct PorA proteins belonged mostly to clonal types that were unrelated to the epidemic strain, whereas all meningococcal isolates expressing variants of P1.7-2,4 PorA belonged to the ST-41/ST-44 complex, lineage III. These results, together with those obtained serologically, demonstrate that the P1.7-2,4 PorA protein of meningococci responsible for New Zealand's epidemic has remained relatively stable over 13 years and support the use of a strain-specific outer membrane vesicle vaccine to control the epidemic.

* Corresponding author. Mailing address: Institute of Environmental Science and Research, P.O. Box 50 348, Porirua, New Zealand. Phone: 64 4 9140778. Fax: 64 4 9140687. E-mail: diana.martin{at}esr.cri.nz.

{dagger} Present address: School of Biomedical Sciences, University of Nottingham, Queens Medical Centre, Nottingham NG7 2UH, England.

Journal of Clinical Microbiology, February 2005, p. 832-837, Vol. 43, No. 2
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.2.832-837.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Beddek, A. J., Li, M.-S., Kroll, J. S., Jordan, T. W., Martin, D. R. (2009). Evidence for Capsule Switching between Carried and Disease-Causing Neisseria meningitidis Strains. Infect. Immun. 77: 2989-2994 [Abstract] [Full Text]  
  • Bayliss, C. D., Hoe, J. C., Makepeace, K., Martin, P., Hood, D. W., Moxon, E. R. (2008). Neisseria meningitidis Escape from the Bactericidal Activity of a Monoclonal Antibody Is Mediated by Phase Variation of lgtG and Enhanced by a Mutator Phenotype. Infect. Immun. 76: 5038-5048 [Abstract] [Full Text]  
  • Welsch, J. A., Granoff, D. (2007). Immunity to Neisseria meningitidis Group B in Adults despite Lack of Serum Bactericidal Antibody. CVI 14: 1596-1602 [Abstract] [Full Text]  
  • Wedege, E., Bolstad, K., Aase, A., Herstad, T. K., McCallum, L., Rosenqvist, E., Oster, P., Martin, D. (2007). Functional and Specific Antibody Responses in Adult Volunteers in New Zealand Who Were Given One of Two Different Meningococcal Serogroup B Outer Membrane Vesicle Vaccines. CVI 14: 830-838 [Abstract] [Full Text]  
  • Martin, D. R., Ruijne, N., McCallum, L., O'Hallahan, J., Oster, P. (2006). The VR2 Epitope on the PorA P1.7-2,4 Protein Is the Major Target for the Immune Response Elicited by the Strain-Specific Group B Meningococcal Vaccine MeNZB. CVI 13: 486-491 [Abstract] [Full Text]  
  • Dyet, K. H., Martin, D. R. (2005). Sequence Variation in the porB Gene from B:P1.4 Meningococci Causing New Zealand's Epidemic. J. Clin. Microbiol. 43: 838-842 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»